hrp0098p2-367 | Late Breaking | ESPE2024

A Novel Case of Lipoatrophy Due to a Non-Pegylated Long-Acting Growth Hormone Somatrogon

Buyukgebiz Atilla , Demir And

Introduction: Recombinant growth hormone (rhGH) treatment has been used for growth hormone (GH) induced short stature since 1985, usually with transient adverse events, while lipoatrophy involves irreversible damage to subcutaneous fatty tissue. Biopsies show mast cells and eosinophils, suggesting destructive inflammation. GH directly increases lipolysis, reduces lipoprotein lipase activity, and decreases mature adipocyte number and volume, inhibiting adipose ...

hrp0086p2-p304 | Diabetes P2 | ESPE2016

Cardiovascular Risk and Long Term Follow-up of Turkish Children with Type 2 Diabetes: Single Center Experience

Guven Ayla , Demir Elif Gokce

Background: Type 2 diabetes (T2DM) increases in parallel with obesity in childhood. T2DM can be associated with cardiovascular risk (CVR) even childhood.Objective: To investigate the presence of CVR criterions in children with T2DM and to detect CVR as the earliest age as possible.Method: This study enrolled 84 (58 Girls) children with T2DM. OGTT was performed in 47 children. Biochemical and hormonal analyses were performed in fast...

hrp0089p3-p300 | Pituitary, Neuroendocrinology and Puberty P3 | ESPE2018

Evaluation of Cases with Pubertal Gynecomastia

Nur Peltek Kendirci Havva , Demir Emre

Introduction and Aim: Pubertal gynecomastia is the transient proliferation of glandular tissue in breasts of men without any endocrin pathology. Relatively higher levels of estrogen than plasma testosteron levels and imbalance between tissue estrogen and testosteron levels are considered to be important in pathogenesis. In this study it is aimed to determine the clinical and laboratory properties of our patients who were diagnosed as pubertal gynecomastia and compare with heal...

hrp0089p3-p365 | Thyroid P3 | ESPE2018

The Reference and Follow-up Signs and Symptoms of the Cases Who Are Diagnosed As Hyperthyroidism

Gokce Demir Elif , Guven Ayla , Yildiz Metin

Objective: Hyperthyroidism is rarely seen in the childhood. In this study, we evaluated the reference sign and symptoms and following laboratory and treatment results of the hyperthyroidism cases.Method: Data of the 78 patients were extracted from hospital records retrospectively. Patients’ height, weight, BMI and laboratory results at the time of diagnosis are recorded. Antithyroid drug doses at the 2th, 6th, 12th months after diagnoses are compare...

hrp0098p1-186 | Pituitary, Neuroendocrinology and Puberty 3 | ESPE2024

Utility of First-Morning-Voided Urinary Total LH in Detecting the Onset of Central Puberty

Demir And , Hero Matti , Main Katharina , Juul Anders

Introduction: Early morning basal serum luteinizing hormone LH) (S-LH) ≥ 0.3 IU/L is a specific marker for the onset of central puberty. In this study, we aimed to investigate the sensitivity and specificity of the first-morning-voided (FMV) total urinary LH (U-LH) to replace this marker.Methods: We re-analyzed our previously published data set of 297 children (145 boys and 152 girls, aged 5-15 years, across Tanner st...

hrp0098p1-187 | Pituitary, Neuroendocrinology and Puberty 3 | ESPE2024

Moderate day-to-day variation in first morning urine total luteinizing hormone levels supports the use of a single determination to identify imminent puberty

Demir And , Hero Matti , Juul Anders , Main Katharina

Objectives: We aimed to study the daily variation in first morning urinary total luteinizing hormone (U-LH) determination and validate it as a noninvasive method for analyzing age- and pubertal stage-related changes in LH immunoreactivity (LH-ir) levels to predict imminent onset of central puberty.Methods: We determined three consecutive first morning total U-LH along with spot serum LH and follicle-stimulating hormone c...

hrp0089p3-p047 | Bone, Growth Plate & Mineral Metabolism P3 | ESPE2018

Evaluation of Bone Mineral Density and Bone Metabolism Markers in Children Diagnosed as Celiac Disease

Nur Peltek Kendirci Havva , Comba Atakan , Demir Emre

Introduction and aim: Metabolic bone disorders due to calsium and vitamin D deficiency are one of the most frequent extraintestinal symptoms in Celiac disease. In this study it is aimed to evaluate bone mineral density in patients with Celiac disease during diagnose and evaluate the factors related to bone mineral metabolism.Material and Method: The study included 43 children diagnosed as Celiac disease between December 2015 and December 2017. Clinical, ...

hrp0089p3-p097 | Diabetes & Insulin P3 | ESPE2018

Evaluation of Relation between Diabetic Education Levels of Type 1 DM Child/Adolescent and Parents and Metabolic Control

Kendirci Havva Nur Peltek , Karayurt Umran , Demir Emre

Introduction and aim: The education of the diabetic patients and their parents is an important phase of diabetic treatment. It is accepted in general that good control in diabetes is not possible without enough knowledge and experience about diabetes. In this study it is aimed to evaluate the relation between diabetic education levels of type 1 DM child/adolescent and parents and metabolic control.Material and method: The study included the patients and ...

hrp0086p1-p221 | Diabetes P1 | ESPE2016

Continuous Glucose Monitoring and Hypoglycemia Unawareness in Children and Adolescents with Type 1 Diabetes

Demir Gunay , Ozen Samim , Cetin Hafize , Darcan Sukran , Goksen Damla

Background: Seeking strict normoglycemia in type 1 diabetes mellitus increases the risk of hypoglycemia, exposing to hypoglycemia unawareness. Hypoglycemia unawareness (HU) is defined as the occurrence of hypoglycemic symptoms directly without autonomic symptoms. This study is designed to determine the incidence of HU in children and adolescents with continuous subcutaneous glucose monitoring system and to assess the effect of structured education to improve awareness.<p c...

hrp0086p2-p532 | Fat Metabolism and Obesity P2 | ESPE2016

Retrospective Evaluation of the Efficiency of Metformin Therapy in Obese Children with Insulin Resistance

Cicek Gizem , Abaci Ayhan , Tuhan Hale , Demir Korcan , Bober Ece

Background: Prevalence of obesity has been rising throughout the world. Dyslipidemia, hypertension, insulin resistance, and type 2 diabetes mellitus (DMT2) (metabolic syndrome) are frequently observed serious complications of obesity. The primary approach in the treatment of metabolic syndrome is improving insulin resistance. Metformin is considered as an option for treatment in children with insulin resistance. During the last decade, numerous studies have been published demo...